BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/20/2025 9:55:24 AM | Browse: 176 | Download: 581
 |
Received |
|
2025-03-16 05:16 |
|
Peer-Review Started |
|
2025-03-16 05:16 |
|
First Decision by Editorial Office Director |
|
2025-04-10 20:05 |
|
Return for Revision |
|
2025-04-10 20:05 |
|
Revised |
|
2025-04-22 17:08 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-05-27 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-05-27 06:39 |
|
Articles in Press |
|
2025-05-27 06:39 |
|
Edit the Manuscript by Language Editor |
|
2025-06-04 18:42 |
|
Typeset the Manuscript |
|
2025-06-16 03:00 |
|
Publish the Manuscript Online |
|
2025-06-20 09:55 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Hepatocellular carcinoma in non-cirrhotic patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Karina Sato-Espinoza, Mayra Valdivia-Herrera, Perapa Chotiprasidhi and Javier Diaz-Ferrer |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Javier Diaz-Ferrer, Associate Professor, MD, Hepatology Service, Department of Digestive Diseases, Hospital Nacional Edgardo Rebagliati Martins, 490 Edgardo Rebagliati Avenue, Lima 15072, Peru. jodf13@hotmail.com |
| Key Words |
Hepatocellular carcinoma; Non-cirrhotic; Metabolic dysfunction-associated steatotic liver disease; Hepatitis B; Hepatitis C; Aflatoxin |
| Core Tip |
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and the incidence of HCC among non-cirrhotic individuals is on the rise, correlating with increasing rates of obesity and metabolic syndrome. Targeted surveillance is advised for high-risk groups, especially those with chronic hepatitis B infection, while it remains unrecommended for individuals with metabolic dysfunction-associated steatotic liver disease. Liver biopsy is the only diagnostic method available for this population, highlighting the need for further non-invasive diagnostic tools. This review aims to summarize the epidemiology, clinical and genetic characteristics, diagnostic methods, and treatment options for non-cirrhotic individuals with HCC. |
| Publish Date |
2025-06-20 09:55 |
| Citation |
Sato-Espinoza K, Valdivia-Herrera M, Chotiprasidhi P, Diaz-Ferrer J. Hepatocellular carcinoma in non-cirrhotic patients. World J Gastroenterol 2025; 31(23): 107100 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i23/107100.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i23.107100 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
